Association between deficiency of mannose-binding lectin and severe infections after chemotherapy

Lancet

Volumn 358, Issue 9282, 2001, Pages 637-638

  Peterslund, Niels Anker ^a   Koch, Claus ^b   Jensenius, Jens C ^c   Thiel, Steffen ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ASPARAGINASE; CARBOHYDRATE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; IDARUBICIN; LECTIN; MANNOSE BINDING PROTEIN; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; SARCOLYSIN; THYMOCYTE ANTIBODY; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HEMATOLOGIC DISEASE; HUMAN; IMMUNITY; INFECTION SENSITIVITY; LEUKEMIA; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; TREATMENT OUTCOME;

EID: 0035949119     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05785-3     Document Type: Article

References (5)

1. Mannose-binding lectin: Structure, function, genetics, and disease associations
2. Antitumor activity of mannose-binding protein in vivo as revealed by a virus expression system: Mannose-binding protein dependent cell-mediated cytotoxicity
3. Mannose-binding lectin deficiency is associated with unexplained recurrent miscarriage
4. Detection of mutations in the mannose-binding lectin (MBL) gene by polymerase chain reaction with sequence specific primers shows promotor variants as a common cause of mannose-binding lectin deficiency
5. Reconstituting opsonizing activity by infusion of mannose-binding lectin (MBL) to mannose-binding lectin-deficient humans